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Enterohemorrhagic and enteropathogenic Es-
cherichia coli (EHEC and EPEC) maintain an ex-
tracellular lifestyle and use a type III secretion
system to translocate effector proteins into
the host cytosol. These effectors manipulate
host pathways to favor bacterial replication
and survival. NleA is an EHEC/EPEC- and re-
lated species-specific translocated effector
protein that is essential for bacterial virulence.
However, the mechanism by which NleA im-
pacts virulence remains undetermined. Here
we demonstrate that NleA compromises the
Sec23/24 complex, a component of the mam-
malian COPII protein coat that shapes intracel-
lular protein transport vesicles, by directly bind-
ing Sec24. Expression of an NleA-GFP fusion
protein reduces the efficiency of cellular secre-
tion by 50%, and secretion is inhibited in EPEC-
infected cells. Direct biochemical experiments
show that NleA inhibits COPII-dependent pro-
tein export from the endoplasmic reticulum.
Collectively, these findings indicate that disrup-
tion of COPII function in host cells contributes
to the virulence of EPEC and EHEC.
INTRODUCTION
The Gram-negative bacterium Escherichia coli is com-
monly found in the intestinal tract of warm-blooded ani-160 Cell Host & Microbe 2, 160–171, September 2007 ª2007 Emals. These commensal bacteria appear in the intestine
shortly after birth and act to maintain intestinal physiology
by aiding host digestive processes and producing essen-
tial nutrients. Other intestinal E. coli strains, however, have
acquired virulence factors that permit them to cause
a wide range of enteric or diarrheal diseases in healthy in-
dividuals. These pathotypes, such as enterohemorrhagic
E. coli (EHEC) and enteropathogenic E. coli (EPEC), are
found worldwide and pose serious medical problems to
the citizens of both developing and developed countries.
In the past 25 years, EHEC such as E. coli O157:H7 has
emerged as a significant public health concern in North
America. Known as the agent for ‘‘hamburger disease,’’
it is traditionally food-borne and is transmitted to humans
through the consumption of raw or undercooked meat,
unpasteurized milk or juice, and manure-contaminated
vegetables such as spinach. Over 70,000 cases of EHEC
infection are estimated to occur each year in the United
States (Mead et al., 1999).
Although the exact mechanisms leading to disease
have not been completely characterized, virulence of
EHEC, EPEC, and related pathogens depends on a type
III secretion system (TTSS), and its effector proteins,
which are translocated into host cells. NleA (also called
EspI) is a recently identified TTSS-translocated effector
protein that is specific to EHEC, EPEC, and related animal
pathogens such as Citrobacter rodentium. The impor-
tance of NleA in pathogenesis was determined in vivo by
infecting susceptible C3H/HeJ mice with wild-type and
an isogenic DnleA mutant strain of C. rodentium. Mice in-
fected with the DnleA strain survived and cleared the in-
fection, whereas wild-type C. rodentium infection caused
the death of all mice between 6 and 10 days postinfection.
These experiments confirm that NleA is necessary forlsevier Inc.
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standing of its mechanism of virulence (Gruenheid et al.,
2004; Mundy et al., 2004). The mechanism by which
NleA impacts virulence remains undetermined; however,
in host cells NleA associates with membranes and local-
izes to a perinuclear compartment that shows significant
overlap with the Golgi marker mannosidase II (Gruenheid
et al., 2004).
To gain a more comprehensive understanding of NleA
function and its effect on bacterial virulence, we investi-
gated the interaction of NleA with host cell proteins and
the functional consequences of these interactions. Here
we provide evidence that NleA compromises protein traf-
fic from the endoplasmic reticulum (ER) and secretion by
binding Sec24, the cargo-determining subunit of the
COPII coat (see Lee et al., 2004).
RESULTS
Interaction of NleA with Components
of Mammalian COPII
EPEC expressing FLAG-tagged NleA was utilized to
deliver NleA-FLAG protein to HeLa cells in a natural infec-
tion process (see Experimental Procedures). In order to
ensure that addition of the FLAG tag to the C terminus of
NleA does not affect the normal function of the protein,
C-terminally FLAG-tagged NleA was tested for virulence
in theCitrobacter rodentiummouse infectionmodel,where
it was found to behave indistinguishably from the wild-
type, untagged protein (Figure S5 in the Supplemental
Data available with this article online). Infected HeLa cells
containing FLAG-tagged NleA were lysed, and FLAG-
tagged NleA and interacting host cell proteins were puri-
fied on anti-FLAG affinity resin. Protein complexes eluted
from the resin are shown in Figure 1A. In addition to
NleA-FLAG, the major protein species present in the gel,
which migrated at approximately 55 kDa, three other pro-
tein species were visible specifically in the sample from in-
fected cells and not in the sample from uninfected control
cells (Figure 1A, arrows). These protein bands were ex-
cised from the gel and identified by mass spectrometry.
A protein with apparent molecular weight 30 kDa (white ar-
row) was identified as a degradation product of NleA. Two
protein species that migrated as a doublet at approxi-
mately 80 kDa (black arrow) were identified as human
Sec23. The identities of NleA and Sec23 were confirmed
by western blot analysis with specific antisera (Figure 1B).
Since Sec23 exists as a heterodimeric complex with
Sec24 in host cells, we analyzed the NleA immunoprecip-
itate for the presence of Sec24 by western blotting and
found it to be present. Closer examination of the total pro-
tein-stained gel revealed faint bands at approximately
120 kDa and 140 kDa, corresponding to the estimated
sizes of Sec24 isoforms in human cells. In contrast, an-
other abundant but unrelated coat protein, b-COP, was
not detected in the immunoprecipitate, although it was
present in the cell lysates (data not shown). Furthermore,
when rabbit antiserum directed against Sec24 was used
to immunoprecipitate the Sec23/24 complex from theCell Host &cell lysates, NleA was coimmunoprecipitated (Figure 1B).
NleA was not present in the immunoprecipitate when
an unrelated antibody was used (a-Nck; Figure 1B). To-
gether, these data indicate that NleA interacts with
Sec23/Sec24 heterodimers inmammalian cells. To ensure
that the interaction was not a result of the addition of the
FLAG-tag to NleA, we verified the interaction of NleA
with Sec23/Sec24 by affinity chromatography using
NleA with an N-terminal his-tag (Figure S1).
NleA Inhibits Secretion in Host Cells
To determine if the interaction of NleA with Sec23/24 af-
fects protein secretion in host cells, we transfected a plas-
mid encoding an NleA-GFP fusion protein into CHO cells,
and the secretion of an alkaline phosphatase reporter pro-
tein (SEAP) was measured. As seen in Figure 2A, when
compared to control cells transfected with a GFP plasmid,
cells expressing NleA-GFP showed a significant reduction
in the secretion index of the reporter protein (mean ± stan-
dard deviation = 51% ± 7% of control; p value in unpaired
Student’s t test = 0.0001). Cells treated with Brefeldin A
(BFA), a drug that inhibits the trafficking of vesicles be-
tween the ER and the Golgi, showed a much greater re-
duction (99%). These reductions were the result of
both less SEAP being secreted into the extracellular me-
dium and more SEAP being retained within cells (data
not shown). However, the BFA-treated cells had less se-
cretion and also more retention of the reporter protein
Figure 1. NleA Interacts with Components of the COPII
Complex
(A) SYPRO-stained SDS-PAGE gel of proteins immunoprecipitated
from uninfected cells (left lane) and cells infected with EPEC express-
ing NleA-FLAG (right lane). Protein bands that were excised and iden-
tified bymass spectrometry are indicated with arrows. Migration of the
molecular weight markers is indicated to the left of the gel (in kDa).
(B) Immunoblot analysis of immunoprecipitations. Immunoprecipita-
tions were performed using the indicated antibodies (IP). Immuno-
precipitated proteins (top three panels, IP) as well as total cell lysates
(bottom panel, lysate) were subjected to immunoblot analysis with the
antibodies indicated to the right of the gels. Samples are shown from
cells infected with EPEC UMD207 expressing NleA-FLAG (right lanes)
and control cells infected with EPEC UMD207 (left lanes).Microbe 2, 160–171, September 2007 ª2007 Elsevier Inc. 161
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(A) Relative secretion index of secreted alkaline phosphatase (SEAP) reporter protein in cells transfected with a plasmid encoding SEAP
and a plasmid encoding GFP (GFP), a GFP-NleA fusion protein (NleA), or treated with Brefeldin A (BFA). Data points represent the mean ± the
standard deviation of six biological replicates for each sample. Significance rating of p value comparing GFP and NleA-GFP samples is
indicated.
(B) Localization of SEAP reporter protein in cells transfected with a plasmid encoding SEAP (SEAP only), in cells transfected with SEAP and a GFP-
expressing plasmid (SEAP + GFP), transfected with SEAP and a plasmid expressing a GFP-NleA fusion protein (SEAP + NleA-GFP), or transfected
with SEAP and treated with Brefeldin A (SEAP + BFA). The first column shows SEAP immunostaining, the second column shows the GFP signal, the
third column shows staining for the Golgi marker Mannosidase II, and the fourth column shows an overlay of the SEAP staining (red) and the Man-
nosidase II staining (blue). Overlap between the two channels is indicated in pink.
(C) Relative secretion index of SEAP reporter protein in uninfected cells (control), or cells infected with wild-type EPEC (WT), EPEC with a chromo-
somal deletion of nleA (DnleA), a type III secretion mutant of EPEC (DescN), or EPEC with a chromosomal deletion of nleA (DnleA) complemented with
a nleA-expressing plasmid (DnleA + nleA). Data points represent the mean ± the standard deviation of six biological replicates for each sample.
Significance rating of p values comparing certain samples are indicated.
(D) Immunoblot analysis of VSVG in cells cotransfected with VSVG and GFP (GFP) or NleA-GFP (NleA) (see Experimental Procedures).
Endoglycosidase-treated (+) and mock-treated () samples from the zero (t = 0) and 45 min (t = 45) time points are indicated. The mobility of
the Endoglycosidase H-resistant (upper band) and -sensitive (lower band) forms of the protein is indicated with arrows on the left side of
the gel.162 Cell Host & Microbe 2, 160–171, September 2007 ª2007 Elsevier Inc.
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of the NleA protein in mammalian cells markedly in-
hibits secretion but does not have as potent an effect
as BFA.
In order to gain further insight into the secretion inhibi-
tion seen in NleA-transfected cells, we determined the lo-
calization of the SEAP protein using immunofluorescence
and confocal microscopy. As shown in Figure 2B, in cells
transfected with SEAP alone (top row) or cotransfected
with SEAP and GFP (second row), SEAP immunostaining
was visible throughout the cell but was particularly con-
centrated in a vesicular perinuclear compartment that
showed significant overlap with a Golgi marker, Mannosi-
dase II. Thus, at steady state, a large amount of SEAP was
localized to the Golgi in control cells. In contrast, in cells
cotransfected with SEAP and NleA-GFP (Figure 2B, third
row), the concentration of SEAP staining at the perinuclear
area and the colocalization of SEAP and Mannosidase II
staining was greatly diminished. In these cells, the SEAP
immunostaining was more evenly distributed throughout
the cytoplasm of cells, in a pattern consistent with locali-
zation to the endoplasmic reticulum. In BFA-treated cells,
the concentration of SEAP staining at the perinuclear area
was also greatly diminished (Figure 2B, bottom row). How-
ever, BFA treatment leads to complete disruption of the
Golgi, and therefore the Mannosidase II staining was dis-
rupted as well. These data provide evidence that, in NleA-
GFP-transfected cells, secretion of SEAP is inhibited
during transport between the ER and Golgi.
We next determined if the NleA-dependent inhibition of
secretion observed in transfected cells was also observed
during bacterial infection. The secretion index of the SEAP
reporter protein was measured in cells infected with vari-
ous EPEC strains. As shown in Figure 2C, in cells infected
with a wild-type EPEC strain, SEAP secretion was signifi-
cantly reduced compared to uninfected control cells
(mean ± standard deviation = 57% ± 11% of control;
p value in unpaired Student’s t test = 0.0001). This effect
was dependent on a functional TTSS, as the secretion in
cells infected with a type III secretion mutant EPEC strain
(DescN) was indistinguishable from that seen in uninfected
control cells (mean ± standard deviation = 100% ± 10% of
control). Thus, cellular secretion is significantly disrupted
during EPEC infection, in a type III-dependent manner. In-
fection of cells with an EPEC strain containing a chromo-
somal deletion of the gene encoding NleA (DnleA) resulted
in a partial restoration of SEAP secretion (mean ± standard
deviation = 80% ± 5% of control). However, secretion of
SEAP in the cells infected with EPEC DnleA was not re-
stored to the levels seen in cells infected with the DescN
mutant (p value 0.0016). This suggests that, although
NleA contributes to the inhibition of secretion seen in in-
fected cells, other type III secreted effectors may also
play a role. Infection of cells with a complemented DnleA
strain reduced SEAP secretion to the level seen in wild-
type EPEC-infected cells (mean ± standard deviation =
59% ± 8% of control). Taken together, these results
indicate that NleA specifically and significantly inhibits
secretion in host cells during infection.Cell Host & MNleA Inhibits the Trafficking of Membrane
Proteins between the ER and Golgi
To gain further evidence that membrane trafficking from
the ER is inhibited in the presence of NleA, we examined
the trafficking of another classical reporter protein, vesic-
ular stomatitis virus glycoprotein (VSV-G). VSV-G tsO45
is a temperature-sensitive variant that, at 40C, misfolds
and is retained in the ER.When cells expressingmisfolded
protein are shifted to 32C, the protein refolds and re-
sumes transport to the Golgi and through the secretory
pathway, with its final localization in the plasmamembrane
of host cells (Bergmann, 1989; Presley et al., 1997). The
transport of VSV-G from the ER to the Golgi is accompa-
nied by a modification of glycosylation on the protein.
The high-mannose glycosylation that is present on the
ER formof the protein is sensitive to the glycosidase Endo-
glycosidase H (Endo H), whereas glycan modification in
the Golgi confers resistance to Endo H digestion (Berg-
mann, 1989). Hence, the sensitivity of VSVG to Endo H
digestion is an indicator of the localization of the protein
within the secretory pathway. To monitor the effect of
NleA on VSV-G trafficking, we transfected CHO cells with
NleA-GFP and VSV-G or GFP and VSV-G. Twenty-four
hours after transfection, the cells were shifted to 40C
overnight, at which point cycloheximide was added to in-
hibit further protein synthesis and the cells were shifted
to 32C for 45 min to allow for mutant VSV-G refolding
and ER export. In the GFP- and VSV-G-transfected cells,
a portion of the VSV-G protein was rendered EndoH resis-
tant at the 45 min time point, indicating transport of some
of the protein to the Golgi (Figure 2D). In contrast, in the
cells transfected with NleA-GFP and VSV-G, VSV-G pro-
tein was sensitive to EndoH digestion at both 0 and 45
min, indicating that, in these cells, the protein is localized
to the ER (Figure 2D). Therefore, in the presence of NleA
the transport of VSV-G between the ER and Golgi is in-
hibited or delayed.
NleA Inhibits COPII-Dependent Cargo Packaging
In order to examine directly the functional consequences
of NleA and Sec23/24 interaction, we determined the ef-
fect of NleA in an in vitro COPII vesicle budding reaction.
Addition of NleA to the budding reaction inhibited vesicle
budding/cargo packaging (Figure 3A). This inhibition was
dosage dependent. We measured NleA concentration
from HeLa cells infected with either EHEC or EPEC (Fig-
ure S1B). Although NleA concentration varied, it ranged
from 70 to 150 nM, which is an effective concentration
for inhibition of COPII cargo packaging in the cell-free as-
say. Sar1 H79G, a mutation that blocks GTP hydrolysis,
potently inhibited cargo packaging in this reaction
(Figure S2A). Higher concentrations of NleA did not inhibit
the budding reaction to the extent of Sar1 H79G
(Figure S2B). This could be due to the role of Sec13/31,
which antagonized the NleA effect (see below). High con-
centration of an unrelated protein, GST, or GST-p58ct,
which has an ER export motif, did not inhibit packaging
of p58, suggesting that NleA effect is specificicrobe 2, 160–171, September 2007 ª2007 Elsevier Inc. 163
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Inhibits COPII-Dependent Cargo Pack-
aging
(A) In vitro COPII vesicle formation assay.
Semi-intact cells (SICs) were prepared from
HeLa cells. The vesicle formation reaction
was performed in the presence of indicated
amount of NleA as described in the Experimen-
tal Procedures. P14, semi-intact cell (input)
fraction; P100, COPII vesicle fraction. Ribo-
phorin I is an ER resident protein that should
not be found in COPII vesicle fractions. APP,
amyloid precursor protein.
(B–D) Microsome flotation analysis. For the mi-
crosome flotation assay, 53microsomes were
used (see Experimental Procedures). (B) NleA
(40 mg/ml) was incubated with microsomes in
the presence of GDPorGMP-PNP, a noncleav-
able GTP analog. (C) Sar1 (10 mg/ml) and
Sec23/24C (10 mg/ml) were incubated with mi-
crosomes in the presence of various nucleo-
tides. (D) Sar1 (10mg/ml), Sec23/24C (10 mg/ml),
and NleA (40 mg/ml) were incubated with micro-
somes.(Figure S2C). Our results indicate that NleA inhibits but
does not completely abrogate COPII function.
NleA Enhances Recruitment of Sec23/24C
Complex to Microsomal Membranes
Sec23/24 is recruited to the ER by the GTP-bound form of
Sar1 (Sar1-GTP). Because we had shown that NleA binds
Sec23/24 in solution, we next tested if NleA could be re-
cruited to the ER through Sec23/24. Microsomes were
mixed with purified recombinant proteins (NleA, hamster
Sar1, and mouse Sec23A /human Sec24C) in the pres-
ence of various nucleotides and applied in the bottom
layer of a Nycodenz step gradient. Ribophorin I, an ER res-
ident protein, equilibrated near the top of the gradient in all
conditions, indicating flotation of ER membranes (Figures
3B–3D). In the absence of COPII components, NleA ex-
hibited negligible flotation, regardless of the nucleotide
addition (Figure 3B). In control experiments in the absence164 Cell Host & Microbe 2, 160–171, September 2007 ª2007 Eof NleA, GDP did not support Sar1/Sec23/24C mobiliza-
tion onto the membrane (Figure 3C, left panel). However,
Sar1 and Sec23/24C recruitment to the membrane was
clearly evident in the presence of GMP-PNP, a nonhydro-
lyzable GTP analog (Figure 3C, middle panel). Although
GTP activates Sar1, which recruits Sec23/24C complex
to the membrane, this ternary complex is short lived be-
cause Sec23 is a GAP for Sar1 (Antonny et al., 2001).
The rapid conversion of Sar1-GTP to Sar1-GDP results
in Sec23/24 dissociation from the membrane. As expec-
ted, GTP did not stabilize Sar1 and Sec23/24C on the
microsomes (Figure 3C, right panel).
NleA stimulated the recruitment of Sec23/24C and NleA
tomicrosomes in the presence of GMP-PNP, and to lesser
extents with GTP and GDP (Figures 3C and 3D). Because
NleA stabilized Sec23/24C on the membrane without
a concomitant increase in Sar1 binding (Figures 3C and
3D, right panels), it is conceivable that NleA helps to recruitlsevier Inc.
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and Sec23/24C
(A–D) Liposome flotation assay. Combinations
of Sar1 (1 mg), Sec23A/24C (1 mg), Sec13/31A
(1 mg), and NleA (4 mg) were added into the re-
action mixture. The final concentration of nu-
cleotide was 0.1 mM. The reaction mixture
was incubated at 27C for 10 min. Floated ma-
terial was normalized to the lipid recovery so
that the same amount of lipid would be applied
to SDS-PAGE. An aliquot (5%) of input material
was loaded onto the gel for comparison. The
asterisk represents an impurity that copurifies
with Sar1.
(E) Enzyme-linked immunosorbent assay
(ELISA). NleA binding to Sec23A (filled trian-
gles), Sec24C (filled circles), or BSA (open
squares) was detected using an anti-NleA
primary antibody and horseradish peroxidase
secondary antibody followed by a colorimetric
peroxidase substrate (see Experimental Pro-
cedures). The graph shows absorbance of
the colorimetric substrate at 490 nm verses
the amount of NleA added to the assay. Data
points represent the mean ± the standard
deviation of triplicate wells.oligomeric Sec23/24C to the membrane or that Sec23/
24C/NleA binds to preexisting Sar1/Sec23/24/NleA with-
out further recruitment of Sar1.
Sec23/24C Recruits NleA to Synthetic Liposomes
It is formally possible that membrane proteins on the mi-
crosomes contribute to the stabilization of the ternary
complex. To identify minimal requirements for NleA re-
cruitment to a membrane, we used chemically defined
liposomes as a binding platform (Figure 4) and performed
a liposome flotation assay (Kim et al., 2005). In this assay,
a noncleavable GTP analog, GTP-g-S, stimulates Sar1
binding to liposomes (Figure 4A). A fraction of mammalian
Sar1 binds to the liposome even in a GDP-bound state
(Kim et al., 2005). Sar1 alone did not promote NleA binding
to the liposome, and NleA alone did not bind the lipo-
somes (Figure 4A). Similarly, Sec23 alone did not recruit
NleA to the liposome (Figure 4B). However, the Sec23/
Sec24C heterodimer recruited NleA in rough stoichiomet-
ric equivalence (Figure 4C). These results suggest that
Sec24C or the interface of the Sec23/24C complex is
the binding target of NleA. NleA binding was also facili-Cell Host &tated when the full set of COPII proteins were mixed under
conditions of coat polymerization (Figure 4D). Thus, NleA
appears to bind to a component of the COPII coat and
to be assembled on a membrane without a requirement
for membrane proteins.
Direct Binding of NleA to Sec24C
In the liposome-bindingassay, interactionbetweenSec23/
24C andNleA is sufficient to recruit NleA on themembrane
in the presence of Sar1 andGTP-g-S (Figure 4C). Because
Sec24C does not directly interact with Sar1 and would not
be recruited to liposomes in the absence of Sec23, we
could not use the liposome flotation assay to address the
direct binding partner of NleA. To detect the interaction
of NleA and Sec24C, we used an ELISA-based assay
with purified proteins (Goosney et al., 2000). As shown in
Figure 4E, NleA bound Sec24C directly in a saturable and
concentration-dependent manner.
NleA Stabilizes Sec23/24C in the Presence of GTP
on a Synthetic Liposome
Although GTP supports transient recruitment of COPII
proteins to the membrane, COPII proteins are releasedMicrobe 2, 160–171, September 2007 ª2007 Elsevier Inc. 165
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stimulates Sar1 GTP hydrolysis (Antonny et al., 2001).
This uncoating phenomenon is particularly striking on
the liposomal surface to the extent that COPII vesicle for-
mation does not occur with GTP (Matsuoka et al., 1998).
However nonhydrolyzable GTP analogs enable COPII
vesicle formation on the liposome (Matsuoka et al.,
1998). Because NleA stabilized Sec23/24C on micro-
somes in the presence of GTP (Figure 3D), we tested
whether this stabilization occurs on the liposomal surface
(Figure 5). Indeed, in the presence of NleA, Sec23/24C re-
mained associated with liposomes even in the presence of
GTP (Figure 5A), although to a lesser extent than in incuba-
tions containing GTP-g-S.
We reasoned that NleA might inhibit the GAP activity of
Sec23. To test this possibility, we performed a tryptophan
fluorescence assay in which the nucleotide-bound state of
Sar1 is monitored by a reduction of fluorescence as Sar1-
GTP is converted to Sar1-GDP (Antonny et al., 2001). In
the presence of synthetic liposomes, Sar1-GTP decayed
to Sar1-GDP upon addition of the Sec23/Sec24C com-
plex (Figure 5B). Preincubation of Sec23/24C with NleA
resulted in a dose-dependent reduction in GTP hydrolysis
to a maximum of about 2.5-fold lower than the control.
However, no reduction was observed without preincuba-
tion of NleA and Sec23/24C (data not shown). Further-
more, GAP inhibition depended on the presence of
Sec24 (data not shown), consistent with the previous re-
sults that NleA interacts directly with Sec24C. Sec13/31,
which stimulates GAP activity of Sec23/24C on Sar1, an-
tagonized the effect of NleA on Sec23/24C (Figure 5C).
Thus, NleA may interfere with an early event in COPII
coat assembly.
NleA Stabilizes COPII Cage Formation
To gain further insight into the mechanism of COPII inhibi-
tion by NleA, we investigated the effect of NleA on COPII
cage formation. Purified yeast Sec23/24p and Sec13/
31p spontaneously assemble to form empty COPII cages
at low-salt, slightly acidic pH, or at 4C (Antonny et al.,
2003). The mammalian Sec13/31 complex alone polymer-
izes to form a cuboctahedron structure (Stagg et al.,
2006). Using dynamic light scattering (DLS) measure-
ments, we observed Sec13/31 particles with a hydrody-
namic radius of about 40 nm at 4C (Table 1), consistent
with dimensions reported previously. Particle formation
was reversible and dependent upon incubation tempera-
ture, suggesting that the binding force between Sec13/
31 proteins is not strong enough to withstand thermal mo-
tion at 25C or is stabilized by hydrophobic interactions at
4C. When Sec23/24 and Sec13/31 were mixed, com-
plexes formed a larger particle with a radius of 210 nm
at 4C. Such large particles did not form at 25C, and as-
sembly was reversed on transfer of samples from 4C to
25C. The larger particles may reflect a normal aspect of
COPII cage formation in the absence of membranes.
The influence of NleA binding on COPII complexes and
cage formationwas evaluated byDLSmeasurement. NleA
interacted with Sec23/24C to form irregular structures, the166 Cell Host & Microbe 2, 160–171, September 2007 ª2007 Elargest of which were removed by centrifuging samples at
15,000 rpm in a bench top centrifuge. When such aggre-
gates were removed, the supernatant fraction contained
small particles that grew in size at 4C and persisted
Figure 5. NleA Stabilizes Sec23/24C in the Presence of GTP
on the Synthetic Liposome
(A and C) Liposome flotation assay. See the legend of Figure 4 for
detail. M, protein standard marker (200, 116, 97.4, 66.2, 45, 31, and
21.5 kD). (B) Tryptophan fluorescence assay of Sar1-GTPase. This as-
say was performed essentially as described using a major-minor syn-
thetic liposome mix containing 10% cholesterol (8), at 30C. At time 0,
Sec23A/Sec24C was added to a mixture of Sar1-GTP and liposomes,
and tryptophan fluorescence was monitored. The decrease in signal
represents hydrolysis of Sar1-GTP to Sar1-GDP. Concentrations: lipo-
somes, 300 mM; Sar1, 2 mM; GTP, 30 mM; Sec23A/Sec24C, 125 nM;
NleA, as indicated.lsevier Inc.
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incubation, particle aggregates were generated again.
NleA and Sec24C behaved much like NleA and
Sec23/24C, whereas NleA and Sec23A did not form
oligomers or aggregates. We conclude that NleA causes
irregular aggregation of the Sec23/24C heterodimers.
Although NleA had no effect on Sec13/31 particle for-
mation, addition of Sec23/24C to this mixture produced
particles with radii ranging from 100 to 170 nm, similar to
those formed in the absence of NleA. However, irregular
aggregates such as were observed without Sec13/31
seemed less abundant. Most importantly, NleA-Sec23/
24C-Sec13/31 particles were stably detected in samples
incubated at 25C. These results suggest that NleA may
promote the formation of stable COPII complexes in
infected cells.
NleA Carboxy-Terminal Residues Are Critical
for Modulation of Cargo Packaging
To identify the regions of NleA responsible for effects on
COPII vesicle formation, we purified NleA fragments
using constructs for amino-terminal fragment (NTF) and
carboxy-terminal fragment (CTF). CTF was still inhibitory
in cargo packaging, whereas NTF was not inhibitory
Table 1. Hydrodynamic Radius of Particles in
Nanometersa
Temperature (C)b
25 4 25 4
NleA 14.7 19.1
23A 12.6 14.2
23A + NleA 13.7 14.3
24C 8.4/28.5 9.1/29.1
24C + NleAc 7.5/35.1 125.8/266.9d >175d
13/31 11.6 39.2 12 39.8
13/31 + NleA 13.7 32 14.1 43.3
23A/24C 10.6 11.9 12
23A/24C + NleAc 13.4 192d 182.2d
23A/24C + 13/31 14.7 214 14.4 217.3
23A/24C + 13/31
+ NleA
171.3 105.9 143.9 142.5
a Proteinsampleswereclearedbycentrifugationat 55,000 rpm
for 5 min at RT with a TLA 100.3 rotor. Each component was
mixed for 5 min at RT and subject to light scattering measure-
ments.
b Temperatures were successively changed in the instrument
starting from 25C, and measurements were made after the
target temperature was stabilized.
c Because of irregular aggregation, directmeasurements were
not possible. Large aggregates were first removed by centri-
fugation at 14,000 rpm for 5 min at RT using an Eppendorf
centrifuge (5415C), and supernatant was used for measure-
ments.
d Aggregates gained size during measurements. Measure-
ments were essentially impossible at later time points.Cell Host &(Figure 6A). Interestingly, both fragments were able to
bind Sec23/24 independently (Figure 6C). Binding of NTF
to Sec23/24 per se was dispensable for modulation of
cargo packaging. Because the C-terminal residues of
NleA are highly conserved among NleA proteins, and be-
cause these residues have been shown to be important
for binding a partial protein fragment of Sec24 in a yeast
two-hybrid assay (E.L.H. and S.F.L., unpublished data),
we deleted four residues (ETRV) from full-length (FL) NleA
and fromCTF. Both FLDETRV and CTFDETRV lost their in-
hibitory effects on cargo packaging (Figure 6B). However,
deletion of ETRV motif did not compromise binding to
Sec23/24 (Figure6D),and thesemutantsstill boundpurified
full-length Sec24C in an ELISA (Figure S3) suggesting that
interaction between NleA and Sec24 is complex, with at
least three portions of NleA that make contact with Sec24.
We tested whether cargo packaging inhibition of NleA
variants and their effect on Sec23/24 assembly are corre-
lated (Table S2). NTF did not have any effect on Sec23/24
particle size, whereas FL and CTF caused Sec23/24 to
form large irregular particles at low temperature. DETRV
did not induce an increase in Sec23/24 particle size at
25C. When the temperature was lowered, small particles
grew in size at 4C that persisted when samples were
warmed to 25C (Table S2). These results strongly sug-
gest that the ETRV motif of NleA interferes with COPII
function through abnormal assembly of Sec23/24.
Binding of NleA fragments to Sec24 was also tested
using ELISA (Figure S3). The C-terminal portion of NleA
forms a stable complex with Sec24. Although NleA-NTF
binding to Sec24C was reduced, the Sec23/24C/NleA-
NTF complex was stabilized on liposomes (Figure 6C).
Lipids may play an important role in the interaction of
NleA and Sec24, or the N-terminal of NleA may bind pref-
erentially to a Sec23/24 heterodimer.
We also tested whether the ETRVmotif was responsible
for stabilization of Sec23/24 on a liposomal surface (Fig-
ure S4). Here we monitored the stabilization of Sec23/24
complex in the presence of GTP byNleA variants. Interest-
ingly, both FL-DETRV and CTF DETRV stabilized the
Sec23/24-Sar1GTP complex to the FL or CTF level, re-
spectively (Figure S4). Although the ETRV motif is critical
for inhibiting cargo packaging, other portions of NleA
play an important role in abnormal assembly of Sec23/
24 on the membrane. It is possible that this stabilization
may also compromise fusion of COPII vesicles with ac-
ceptor membranes.
To determine the contributions of the ETRV-dependent
and ETRV-independent effects on COPII described above
to the overall inhibition of secretion by NleA, we compared
the inhibition of SEAP secretion in cells transfected with
either full-length NleA-GFP or NleADETRV-GFP (Fig-
ure S5A). NleADETRV-GFP-transfected cells had an inter-
mediate phenotype, displaying an inhibition of secretion
that was at 64% of the level of inhibition seen in the full-
length NleA-GFP-transfected cells (Figure S5A). The dif-
ference in inhibition between the NleA-GFP and NleA-
DETRV-GFP was significant (p value < 0.0001 in unpaired
Student’s t test).Microbe 2, 160–171, September 2007 ª2007 Elsevier Inc. 167
Cell Host & Microbe
NleA Disrupts Mammalian COPII FunctionFigure 6. The C-Terminal ETRV Motif Is
Crucial for Inhibitory Effect of NleA on
Cargo Packaging
(A and B) In vitro COPII vesicle formation as-
say. Assay conditions are described in the
legend of Figure 3A. Note that even at a low
concentration of full-length NleA (7.5 nM),
packaging of cargo molecules was not fully
recovered.
(C and D) Liposome flotation assay. See the
Experimental Procedures for detail. Combina-
tions of Sar1 (1 mg), Sec23A/24C (1 mg), and
NleA variants (FL, 2.4 mg; FL DETRV, 2.4 mg;
NTF, 0.7 mg; CTF, 0.8 mg; CTF DETRV, 0.8 mg)
were added into the reaction mixture.In order to test the contribution of the ETRV motif on
bacterial virulence, we constructed a DnleA mutant strain
of C. rodentium with a plasmid encoding either full-length
NleA or NleADETRV, and the bacterial strainswere used to
infect C3H/HeJ mice (Figure S5B). Comparison of the sur-
vival curves of mice infected with the two strains revealed
a modest but significant and reproducible effect of the
ETRV motif on virulence (p value 0.0175; median survival
time 9 versus 10.5 days).
DISCUSSION
We have shown here that the bacterial virulence protein
NleA interacts with the COPII complex and inhibits its
function. Our results suggest that inhibition is achieved
through perturbation of COPII protein dynamics. The
highly conserved C-terminal ETRV motif is crucial in this
regard because C-terminal truncation of NleA abrogated
toxic effects of NleA in abnormal Sec23/24 assembly
and COPII cargo packaging. NleA also stabilized the
Sec23/24C complex on synthetic liposomes as well as
on native ER microsomes (Figures 3 and 5). However,
the ETRV motif appears dispensable for this activity be-
cause CTF DETRV still stabilized Sec23/24 on the liposo-
mal surface. This stabilization activity may interfere with
vesicle uncoating and fusion. By analogy, nonhydrolyz-
able GTP analogs that stabilize COPII proteins on the ves-168 Cell Host & Microbe 2, 160–171, September 2007 ª2007icle surface inhibit fusion of COPII vesicles to acceptor
membrane (Barlowe et al., 1994). Therefore, NleA may af-
fect ER export at the vesicle budding and fusion steps.
Consistent with this model, NleADETRV partially lifted
the secretion block of alkaline phosphatase (Figure S5A),
and virulence of C. rodentium harboring nleA DETRV
was reduced somewhat (Figure S5B).
As reported previously, Sec13/31 forms a cuboctahe-
dron cage (Stagg et al., 2006). We observed that Sec13/
31 adjusted to form an apparently larger cage including
Sec23/24. In order to accommodate this apparent size in-
crease, Sec13/31 may adopt an alternative geometry. We
observed regular cages formed by Sec23/24-Sec13/31
but found no difference in the appearance of cages
formed in the presence of NleA, other than that NleA sta-
bilized these structures at 25C (Table 1 and unpublished
data by J.K., R.S., S. Hamamoto, and L. Orci). NleA may
serve as a seed for Sec23/24C and Sec13/31 oligomeriza-
tion or a crosslinker for Sec23/24C molecules.
NleA DETRV no longer induced formation of large parti-
cles of Sec23/24 at 25C, yet it maintained an aberrant as-
sembly once the structure was formed by lowering the
temperature (Table S2). Similarly, NleA DETRV may poly-
merize Sec23/24 to a stable form on the surface of a lipo-
some even in the presence of Sar1-GTP (Figure S4).
Lipids play an important role in membrane recruitment
of Sec23/24 (Matsuoka et al., 1998). We showed that,Elsevier Inc.
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with Sec24 (Figure S3), the interaction between NleA-NTF
andSec23/24was stable on the liposome (Figure 6C). This
could be due to the fact that anionic lipids stabilize Sec23/
24 on the liposomal surface, or that NleA-NTF has a spe-
cific affinity for the Sec23/24 heterodimer. It is also possi-
ble that NleA-NTF itself has an affinity for lipids.
Our results provide evidence that EHEC, EPEC, and re-
lated pathogens disrupt COPII-dependent protein traffick-
ing as a virulence strategy in host cells. However, due to
the central role of COPII in protein secretion and trafficking
in host cells, it is hard to pinpoint the exact physiological
consequence of this disruption that benefits the bacteria.
Subtilase cytotoxin produced by certain Shiga toxigenic
bacteria inactivates the ER chaperone BiP, which assists
folding of newly synthesized secretory proteins (Paton
et al., 2006). A secretion defect imposed by an acute
loss of BiP function may enhance bacterial infectivity. Le-
gionella and Brucella are both intracellular bacterial path-
ogens that require COPII-dependent pathways to build
a membrane-bound replicative niche inside host cells
(Celli et al., 2005; Kagan and Roy, 2002). In the absence
of functional Sar1 protein, both Legionella and Brucella
are unable to replicate (Celli et al., 2005; Kagan and Roy,
2002). However, a similar scenario is unlikely with EHEC
and EPEC, as they are extracellular pathogens whose rep-
licative niche is outside of host cells. Given that EHEC and
EPEC are extracellular, it is reasonable to speculate that
these pathogens disrupt COPII in order to manipulate pro-
teins secreted by or expressed at the plasma membrane
of host cells. Bacterial pathogenesis could be enhanced
by a dampening of the cell’s ability to secrete antibacterial
proteins or peptides or by manipulating the cell surface
expression of proteins important in the host response to
infection. Future studies on the physiological conse-
quences of the NleA/COPII interaction during infection
should provide further insight into novel aspects of bacte-
rial pathogenesis and host defense.
EXPERIMENTAL PROCEDURES
Oligonucleotide Sequences, Molecular Techniques,
Antibodies, Bacterial Strains, and Growth Conditions
Bacterial strains, antibodies, and oligonucleotides used in this study
can be found in Table S1. For routine cloning, transformation, and in-
fections, bacteria were grown in Luria-Bertani (LB) agar or LB broth
supplemented with appropriate antibiotics at 37C. Various antibiotics
were used at the following concentrations: 100 mg/ml ampicillin, 50 mg/
ml kanamycin, and 30 mg/ml chloramphenicol. Chinese hamster ovary
and HeLa cells weremaintained inminimal Eagle’s media a (Invitrogen)
and Dulbecco’s modified Eagle’s medium (Invitrogen) with 10% inac-
tivated fetal calf serum (Hyclone) respectively.
Expression and Purification of Proteins
Full-length NleA was expressed and purified as described previously
(Gruenheid et al., 2004). Expression constructs for NleA NTF, CTF,
DETRV, and CTF-DETRV were created by PCR amplification using
Elongase (Invitrogen), of the desired segments of the NleA gene from
EHEC genomic DNA using the primers indicated in Table S1. PCR
products were cloned using the Topo cloning system (Invitrogen), ver-
ified by sequence analysis, and subcloned into NdeI/EcoRI-digested
pET28a (DETRV) or BamHI/EcoRI-digested pET28b (NTF, CTF, CTF-Cell Host & MDETRV) vectors. Plasmids were transformed into BL21-DE3-pLysS
cells, and protein expression and purification on Ni-NTA agarose
was performed according to standard protocols (QIAGEN). In some
cases, an additional wash was performed with 5 mM ATP and 5 mM
MgCl2. Hamster Sar1 protein, mouse Sec23A/human 24C, human
Sec13/31A, and GST-p58ct were purified as described previously
(Kim et al., 2005). The amino acid sequence of mouse Sec23A is
99% identical to that of human Sec23A. Sf9 cells infected with either
Sec23A/His6Sec24C or Sec13/His6Sec31A viruses were lysed by son-
ication in a lysis buffer (20 mM HEPES [8.0], 500 mM KOAc, 250 mM
sorbitol, 10% glycerol, 10 mM imidazole, 0.1 mM EGTA, 5 mM b-mer-
captoethanol) supplemented with a protease inhibitor cocktail tablet
(13, Roche). The lysate was cleared by successive centrifugation in
a Sorvall SS34 rotor for 30 min at 15,000 rpm and in a Beckman 45
Ti rotor for 1 hr at 40,000 rpm. The cleared lysate was incubated
with prewashed Ni-agarose resin for 1 hr at 4C and poured into a col-
umn. The column was washed first with the lysis buffer and washing
buffer (lysis buffer with 50 mM imidazole) and eluted with elution buffer
(lysis buffer with 250 mM imidazole). Eluates were pooled, aliquoted in
a small volume, snap frozen in liquid nitrogen, and kept at 80C.
Immunoprecipitation
The nleA open reading frame without a stop codon was PCR amplified
from EHEC genomic DNA and cloned into XhoI/KpnI-treated pFLAG-
CTC (Sigma). This was introduced into the EPEC strain UMD207 by
electroporation to create EPEC UMD207-NleA-pFLAG-CTC. For pro-
teomic analyses, 20 subconfluent 150 mm dishes of HeLa cells were
infected with 100 ml of an overnight culture of EPEC UMD207-NleA-
pFLAG-CTC. These strains lack intimin and the bundle-forming pilus
and therefore deliver NleA-FLAG in the absence of stable bacterial ad-
herence (Donnenberg and Kaper, 1991). Twenty subconfluent 150mm
dishes of uninfectedHeLa cells were processed in parallel as a control.
After 7 hr, cells were transferred to ice, washed, and gently scraped
into PBS containing calcium and magnesium. Cells were harvested
by centrifugation at 1500 3 g for 5 min, lysed in 5 ml RIPA buffer
(150 mM NaCl, 50 mM Tris [pH 8], 0.4 mM EDTA, 10% glycerol, 1%
NP-40, Complete protease inhibitor [Roche]). After centrifugation at
full speed in a microfuge at 4C for 15 min, supernatants were pre-
cleared with 100 ml of prewashed protein G Sepharose (GE Biosci-
ences). Supernatants were then incubated with 50 ml of prewashed
anti-FLAG agarose (Sigma). Samples were washed with 10 ml RIPA
buffer at 4C, and immunoprecipitated proteins were eluted using
200 ml/sample 360 ng/ml FLAG peptide (Sigma) in RIPA buffer without
NP-40 and precipitated with 10% trichloroacetic acid (Fisher). Pellets
were resuspended in Laemmli buffer and run on SDS-PAGE gels. Gels
were stained with SYPRO Ruby (Bio-Rad), and bands of interest were
excised manually. In-gel tryptic digestion of proteins and mass spec-
trometry analysis were performed as described elsewhere (Gruenheid
et al., 2004). For immunoblot analysis, one 100 mm dish of confluent
HeLa cells was infected for each sample as above. Each dish was
lysed in 1 ml RIPA buffer, and immunoprecipitation was performed us-
ing 40 ml anti-FLAG agarose (Sigma) or 5 ml of rabbit polyclonal anti-
sec24C or anti-Nck antiserum followed by addition of 50 ml of protein
G agarose (Sigma). Immunoprecipitated samples and cell lysates were
then subjected to immunoblot analysis with the indicated antibodies.
Preparation of Microsomes and Semi-Intact Cells
Cells grown to 70%–80% confluency on 10 cm dishes were washed
once with PBS, scraped into PBS (5 ml/dish), pooled, and harvested
at 1000 3 g for 5 min at 4C. The pellet was resuspended in PBS
(0.5 ml/dish) and centrifuged again at 1000 3 g for 5 min at 4C. The
pellet was then resuspended in buffer F [10 mM HEPES-KOH (pH
7.2), 250 mM sorbitol, 10 mM KOAc, 1.5 mM Mg(OAc)2 plus protease
inhibitor cocktail] (0.2 ml/dish), passed through a 22-gauge needle
20 times, and centrifuged at 10003 g for 5min at 4C. The postnuclear
supernatant fraction was removed into siliconized microcentrifuge
tubes, and microsomes were sedimented at 6000 3 g for 10 min at
4C. Harvested microsomes were washed twice with buffer Gicrobe 2, 160–171, September 2007 ª2007 Elsevier Inc. 169
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0.5 mM Mg(OAc)2 plus protease inhibitor cocktail] (0.1 ml/dish), and
the pellet was resuspended in buffer G (30 ml/dish). A microsome sus-
pension (30 ml) wasmixed in 0.5ml buffer G for themeasurement of ab-
sorbance (600 nm). Normally, at an A600 = 0.025, 30 ml of the original
microsome suspension was used for a 100 ml budding reaction (13).
The method to prepare semi-intact cells (SIC) has been previously
described (Kleizen et al., 2005; Wilson et al., 1995). A SIC suspension
(5 ml) was mixed in 0.5 ml KHM buffer (25 mM HEPES [7.0], 110 mM
KOAc, 1 mM MgCl2) for the measurement of absorbance (600 nm).
Normally, at an A600 = 0.025, 8 ml of the original microsome suspen-
sion was used for a 100 ml budding reaction (13).
Microsome Flotation Assay
Microsomes (53) were incubated with various combinations of ham-
ster Sar1a (5 mg/ml), mouse Sec23A/human 24C (5 mg/ml), and NleA
(10 mg/ml) for 1 hr at RT. An ATP regenerating system (40 mM creatine
phosphate, 0.2 mg/ml creatine phosphokinase, and 1mMATP) and ei-
ther 0.2 mMGDP, GTP-g-S, or GTP were included in the reaction mix-
ture. The reaction mixture was supplemented with the same volume of
70% Nycodenz in B88 [20 mM HEPES (7.0), 150 mM KOAc, 250 mM
Sorbitol, 5 mM Mg(OAC)2]. An aliquot (0.6 ml) of this mixture was
placed at the bottom of a tube (Beckman 347356) and subsequently
layered with 0.5 ml of 30%, 25%, and 15% Nycodenz in B88. The gra-
dient was centrifuged for 2 hr at 40,000 rpm in a Beckman TLS-55 rotor
at 4C. Membranes at the 25%–15% interface were manually col-
lected in fractions of 0.4 ml from the top of the gradient, vortexed
vigorously, and applied to SDS-PAGE after solubilization in 23 SDS-
PAGE sample buffer.
Liposome Flotation Assay
The mamDAG liposome was prepared from the mamDAG mix lipid
formulation as described earlier (Kim et al., 2005). For a mammalian
COPII-binding experiment, 15 mg of a liposome suspension wasmixed
with various combinations of hamster Sar1a (1.2 mg), Sec23A/24C
(1.7 mg), Sec13/31A (2.4 mg), and NleA (4.8 mg) in 75 ml of HKM buffer
with an indicated nucleotide (0.1 mM). After incubation for 25 min at
27C, the reaction mixture was diluted with 50 ml of HKM containing
2.5Msucrose. An aliquot (110 ml) of thismixturewas loaded into a poly-
carbonate centrifuge tube (Beckman 343775) and overlaid with 100 ml
of HKM containing 0.75 M sucrose and 20 ml of HKM. The resulting
step gradient was centrifuged at 100,000 rpm in a Beckman TLA-
100 rotor for 20 min at RT. A sample (25 ml) was collected from the
top of the tube. Proteins in the fraction were normalized to the lipid re-
covery, resolved by SDS-PAGE, stained by SYPRO Red, and visual-
ized using a Typhoon 9400 image analyzer.
In Vitro COPII Vesicle Formation Assay
Each reaction contained 20 mM HEPES-KOH (pH 7.2), 250 mM sorbi-
tol, 150 mM KOAc, 0.5 mMMg(OAc)2, protease inhibitor cocktail (13),
and SIC in a 100 ml final volume. Where indicated, an ATP regenerating
system (40 mM creatine phosphate, 0.2 mg/ml creatine phospho-
kinase, and 1 mM ATP), 0.2 mM GTP, NleA (as indicated), and cytosol
(5mg/ml) were added. Reactions were initiated at 25Cand terminated
by transferring tubes to ice after 60 min. A 75 ml aliquot of the vesicle
fraction (S14) was separated from the donor SIC fraction (P14) by cen-
trifugation at 14,000 3 g for 20 min at 4C. The vesicles from the S14
were collected by centrifugation at 50,000 rpm at 4C in a Beckman
TLA100 rotor for 20min (P100). P14andP100 fractionswere solubilized
with 16 ml and 60 ml of buffer C (10mM Tris-HCl [pH 7.6], 100mMNaCl,
1% [w/v] SDS plus protease inhibitor cocktail), respectively, and sup-
plemented with 4 ml and 15 ml of buffer D (150 mM Tris-HCl [pH 6.8],
15% SDS, 25% [v/v] glycerol, 0.02% [w/v] bromophenol blue, and
12.5% [v/v] 2-mercaptoethanol), respectively. The resulting samples
were heated at 42C for 15 min. Aliquots of P14 (20 ml; 75% of total)
and P100 (15 ml; 20% of total) were separated by SDS-PAGE, trans-
ferred to PVDF membranes, and analyzed by immunoblotting.170 Cell Host & Microbe 2, 160–171, September 2007 ª2007 ELight Scattering Measurement
The light scattering assay was performed in a DynaPro (Protein Solu-
tion) Titan (Wyatt Technology Corp., Santa Barbara, California). A
15 ml solution containing the amount of protein indicated in the table
was placed in a quartz cuvette. After equilibration at the desired tem-
perature, ten autocorrelation functions of the scattered light were
determined at the optimal laser intensity, each for 10 s.
ELISA
The protein/protein interaction ELISA was performed as described
previously (Goosney et al., 2000).
Reporter Assays
Secretion Assays
Plasmids encoding secreted alkaline phosphatase (SEAP) (a gift from
Craig Roy), NleA-pEGFP-C1 (Gruenheid et al., 2004), and pEGFP-
C1(Clontech) were isolated using GenElute HP Endotoxin Free Kit
(Sigma). Fugene-6 (Roche) was used to transfect all cell lines with
the indicated plasmids according to the manufacturer’s instructions.
Forty-eight hours after transfection, cells were trypsinized and sorted
by FACS (BD Bioscience FACSAria) to select for cells displaying green
fluorescence. Sorted cells were then plated in 24-well dishes at 7.5 3
104 cells/well. After a 3 hr incubation, fresh tissue culture medium was
added, and some wells were treated with 0.01 mg/ml of brefeldin A
(Bioshop). SEAP activity was measured in triplicate wells 7 hr later us-
ing the Phosphalight SEAP kit (Applied Biosystems). For infection as-
says, CHO cells were plated in 24-well dishes at 5 3 104 cells/well.
Forty-eight hours after transfection, each well was infected with 1 ml
of a 0.5 O.D. culture of the indicated bacteria. After a further 3 hr incu-
bation, each well was washed, and fresh tissue culture media were
added. SEAP activity was measured in triplicate wells 3 hr later. For lo-
calization of SEAP, cells were plated on glass coverslips and trans-
fected as described above. Cells were fixed and processed for immu-
nofluorescence as described previously (Gruenheid et al., 2004) using
anti-alkaline phosphatase and anti-Mannosidase II primary antibodies
and Alexa 568- and Alexa 633-conjugated anti-mouse and anti-rabbit
secondary antibodies (Molecular Probes). Coverslips were mounted in
Prolong gold (Molecular Probes), and single optical sectionswere visu-
alized using an Olympus Fluoview confocal microscope.
VSV-G Assay
CHO cells (2 3 106) were plated in 100 mm tissue culture dishes and
4 hr later were transfected with plasmids encoding VSV-G-ts045-
GFP (a gift from Jennifer Lippincott-Schwartz) and either pEGFP or
pEGFP-NleA using Fugene at a 3:1 ratio according to the manufac-
turer’s directions. Twenty-four hours posttransfection, 25 mM HEPES
(pH 7.4) was added to the medium, and the cells were shifted to 40C
overnight. Next, 20 mM cycloheximide was added, and the cells were
shifted to 32C for 0 or 45 min. Cells were then transferred to ice,
and total membranes were prepared as described previously (Gruen-
heid et al., 2004). Membrane pellets were resuspended by sonication
in 50 mM sodium citrate/ 0.2% SDS (pH 5.5) with complete protease
inhibitors (Roche). After protein concentration determination using
the BCA assay kit (Sigma), equal amounts of membrane proteins
from all samples were treated or mock treated with Endoglycosidase
H (Roche). Samples were then precipitated using 10% Trichloroacetic
acid, resuspended in 23 Laemmli buffer, electrophoresed on a 10%
SDS-PAGE gel, and transferred to PVDF membrane for immunoblot
analysis using an anti-VSV-G antibody.
Generation of nleA Gene Deletion Mutant
The sacB gene-based allelic exchange (Donnenberg and Kaper, 1991)
was used to generate an in-frame deletion mutant of nleA using the
vector pRE112. Primers used are shown in Table S1. This mutant
was verified by PCR reaction spanning the deletion site, and by west-
ern blot analysis with anti-nleA antiserum. The complemented mutant
was created by PCR amplifying the entire nleA sequence and flanking
region using primers EPECkoF1 and EPECkoR2 (Table S1) and, afterlsevier Inc.
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pWSK29.
Supplemental Data
The Supplemental Data include two supplemental tables and five sup-
plemental figures and can be found with this article online at http://
www.cellhostandmicrobe.com/cgi/content/full/2/3/160/DC1/.
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